Ep 51. Infliximab Vs Interferon-α In The Treatment Of Behçet’s Syndrome: Clinical Data From The BIO-BEHÇET’S Randomized Controlled Trial Talking Rheumatology Research podcast

Content provided by British Society for Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by British Society for Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Talking Rheumatology Research »
Ep 51. Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial

11d ago 8:06

MP3•Episode home

In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s.

Listen now to hear the findings and what this means for future clinical practice!

Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology.

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

51 episodes

#Fitness #Medicine #British Society For Rheumatology #Rheumatology #Research #Arthritis #Lupus #Journalism #Disease #Science #Myositis #Vasculitis #Bsr